Interpace Biosciences, Inc.
IDXG
Revenue
8.76M
▼-476.00k▼-5.16%
3 Months ChangeAssets
12.04M
▼-299.00k▼-2.42%
3 Months ChangeLiabilities
12.33M
▼-1.21M▼-8.96%
3 Months ChangeFree Cash Flow
-86.00k
▼-1.15M▼-108.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-20
Form 8-K
ID: 0001493152-26-002772
2025-12-03
Form 8-K
ID: 0001493152-25-025960
2025-11-12
Form 8-K
ID: 0001493152-25-021980
2025-11-12
Form 10-Q
ID: 0001493152-25-021928
2025-08-08
Form 8-K
ID: 0001641172-25-022774
2025-08-07
Form 10-Q
ID: 0001641172-25-022591
2025-05-08
Form 10-Q
ID: 0001641172-25-009275
2025-05-08
Form 8-K
ID: 0001641172-25-009273
2025-05-01
Form 8-K
ID: 0001641172-25-007944
2025-03-06
Form 8-K
ID: 0001493152-25-009384